Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Gabapentin NDC 53217-243 by Aidarex Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image - gabapentin usp 800mg 1
The table shows the recommended daily dose of gabapentin for patients with different levels of renal function, based on their creatinine clearance rate. The dosage ranges from 900 to 1200 mg/day for patients with a creatinine clearance rate of 60 mL/min or greater, to 100 to 700 mg/day for patients with a creatinine clearance rate less than 30 mL/min. Patients on hemodialysis should receive maintenance doses based on the upper portion of the table and also a post-hemodialysis supplemental dose every four hours according to the lower portion of the table. Different abbreviations are provided for the frequency of the doses: TID (three times a day), BID (two times a day), and QD (a single daily dose).*
image - gabapentin usp 800mg 2
image - gabapentin usp 800mg 3
This appears to be a table showing the Risk by Indication for Antiepileptic Drugs in the Pooled Analysis. The table shows the indications for epilepsy, psychiatry and other, as well as the total count of patients. The data presents the risk of events per 1000 patients for both Placebo patients and those given drug patents, along with relative risk and risk difference between the two groups.*
image - gabapentin usp 800mg 4
image - gabapentin usp 800mg 5
The text describes a graph or chart showing the mean pain score during different weeks of a study. The study consisted of a 4-week dose titration period followed by a fixed dose period. The graph shows the mean pain score for both the placebo group and a group of participants taking 3600 mg/day of gabapentin. The graph shows weeks 1-8, including the baseline measurement.*
image - gabapentin usp 800mg 6
image - gabapentin usp 800mg 7
The text provides a figure (Figure 3) showing the proportion of responders in controlled studies for the treatment of post-herpetic neuralgia (PHN). The results suggest that patients with a greater than 50% reduction in pain score were achieved in Study 1 (34%), Study 2 (40%), and Study 3 (50%). The statistical significance reported for Study 1 and 2 is p<0.001. There is also information related to different treatments (GEP 3600, GBP 1800, and GBP 2400), but without sufficient context, it is not possible to provide a useful interpretation.*
image - gabapentin usp 800mg 8
Image Description - gabapentin usp 800mg 9
This is a description of a Gabapentin medication package, with details such as the NDC number, tablet size, and concentration indicated. The medication is manufactured by Invagen Pharmaceuticals and is used to treat seizures and nerve pain. The package contains 30 tablets.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.